Cite
Gemcitabine alters the proteasome composition and immunopeptidome of tumour cells
MLA
John Copier, et al. “Gemcitabine Alters the Proteasome Composition and Immunopeptidome of Tumour Cells.” OncoImmunology, vol. 7, no. 6, June 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....689ee24421c17719a55c8163bedb713b&authtype=sso&custid=ns315887.
APA
John Copier, Stefan Stevanovic, N Trautwein, Angus G. Dalgleish, & Andrew Gravett. (2018). Gemcitabine alters the proteasome composition and immunopeptidome of tumour cells. OncoImmunology, 7(6).
Chicago
John Copier, Stefan Stevanovic, N Trautwein, Angus G. Dalgleish, and Andrew Gravett. 2018. “Gemcitabine Alters the Proteasome Composition and Immunopeptidome of Tumour Cells.” OncoImmunology 7 (6). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....689ee24421c17719a55c8163bedb713b&authtype=sso&custid=ns315887.